Nephrology News & Issues
Since its inception in 1987, Nephrology News & Issues has been at the forefront of reporting on advancements in nephrology. It serves as a platform for professionals involved in renal care to share ideas and insights.
Outlet metrics
Global
#61003
United States
#21938
Health/Health
#505
Articles
-
1 day ago |
healio.com | Justin Cooper
Key takeaways:Misuse of over-the-counter anticholinergics, antihistamines and decongestants is an easily overlooked eye health risk factor. Optometrists should ask patients about their use of over-the-counter drugs. MINNEAPOLIS — Over-the-counter medications can have easily overlooked impacts on eye health if not used appropriately, according to a speaker at Optometry’s Meeting.
-
1 day ago |
healio.com | Justin Cooper
Key takeaways: The first-time pass rate for the first part of the NBEO exam fell from 76.9% in 2015 to 66.71% in 2024. The exam’s average first-time pass rate was the lowest of all comparable exams. MINNEAPOLIS — Students pass the National Board of Examiners in Optometry exam at a “notably lower” rate than similar exams in other areas of health care, according to a poster presented at Optometry’s Meeting. The findings come from research that Jeffrey L.
-
2 days ago |
healio.com | Justin Cooper
Key takeaways:The most common ocular manifestations of long COVID are conjunctivitis and dry eye. Optometrists can play an important role as part of a multidisciplinary management team. MINNEAPOLIS — Optometrists have an important part to play in the management of patients with long COVID, according to a speaker at Optometry’s Meeting.
-
2 days ago |
healio.com | Scott Buzby
Key takeaways: In the SOUL trial, Rybelsus reduced risk for heart events by 14% in patients with diabetes and prior heart and/or kidney disease. New analyses show change in HbA1c or body weight did not impact outcomes. CHICAGO — For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related events, with consistent findings in further analyses, according to new data from the SOUL trial.
-
2 days ago |
healio.com | Scott Buzby
ACC guidance permits use of modern medications as first-line therapy for obesity• An ACC panel states modern obesity medications may be considered as first-line therapy for treatment of obesity. • Patients should not be required to ‘try and fail’ lifestyle changes first, the panel wrote. A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may be considered as the first treatment for patients with obesity.
Nephrology News & Issues journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →